2,5-ANHYDRO-1,3,4-TRIDEOXY-2-C-(2,4-DIFLUOROPHENYL)-4-((4-(4-(4-(1-((1S,2R)-1-ETHYL-2-HYDROXYPROPYL)-1,5-DIHYDRO-5-OXO-4H-1,2,4-TRIAZOL-4-YL)PHENYL)-1-PIPERAZINYL)PHENOXY)METHYL)-1-(1H-1,2,4-TRIAZOL-1-YL)-D-ERYTHRO-PENTITOL
UNII AXE8RR3EPH
Substance Identification & Data
This profile provides standardized clinical and technical data for 2,5-anhydro-1,3,4-trideoxy-2-c-(2,4-difluorophenyl)-4-((4-(4-(4-(1-((1s,2r)-1-ethyl-2-hydroxypropyl)-1,5-dihydro-5-oxo-4h-1,2,4-triazol-4-yl)phenyl)-1-piperazinyl)phenoxy)methyl)-1-(1h-1,2,4-triazol-1-yl)-d-erythro-pentitol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AXE8RR3EPH.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1229428-91-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C37H42F2N8O4 RAGOYPUPXAKGKH-ULDSIUKBSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2,5-anhydro-1,3,4-trideoxy-2-c-(2,4-difluorophenyl)-4-((4-(4-(4-(1-((1s,2r)-1-ethyl-2-hydroxypropyl)-1,5-dihydro-5-oxo-4h-1,2,4-triazol-4-yl)phenyl)-1-piperazinyl)phenoxy)methyl)-1-(1h-1,2,4-triazol-1-yl)-d-erythro-pentitol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.